Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2

QR Code

Cytotoxic effect of 2,6-bis(4-hydroxy-3-methoxybenzylidene) cyclohexanone (BHMC) and curcumin on human liver cancer cells, HepG2

Introduction: Curcumin is an active constituent derived from turmeric with a variety of pharmacological activities. It suppressed cell proliferation and induced apoptosis in several cancer cell lines. However, due to its poor bio-availability, derivative analogue of curcumin has been synthesized to...

Full description

Bibliographic Details
Main Authors:	Syed Alwi, Sharifah Sakinah, Zahari, Syazwan, Haron, Aminah Suhaila, Alexander, Henna Roshini
Format:	Article
Language:	English
Published:	Faculty of Medicine and Health Sciences, Universiti Putra Malaysia 2019
Online Access:	http://psasir.upm.edu.my/id/eprint/70040/ http://psasir.upm.edu.my/id/eprint/70040/1/2019070210005107_MJMHS_SP2_2019.pdf

Similar Items

Development and validation of a bioanalytical method for quantification of 2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) in rat plasma
by: Lee, Yu Zhao, et al.
Published: (2012)

The In Vivo Anti-Tumor Effect of Curcumin Derivative (2E,6E)-2,6-bis(4-hydroxy-3-methoxybenzylidene) Cyclohexanone (BHMC) on 4T1 Breast Cancer Cells
by: Nursyamirah, Abd Razak, et al.
Published: (2017)

The in vivo anti-tumor effect of curcumin derivative (2 E,6 E)-2,6-bis(4-hydroxy-3-methoxybenzylidene)cyclohexanone (BHMC) on 4T1 breast cancer cells
by: Razak, Nursyamirah Abd, et al.
Published: (2017)

Cytotoxicity, proliferation and migration effects of 2,6-bis-(4-hydroxyl-3-methoxybenzylidine)cyclohexanone (BHMC) on human liver cancer, HepG2 cells
by: Mohd Shafiee, Muhammad Aminuddin, et al.
Published: (2024)

Induction of apoptosis and regulation of MicroRNA expression by (2E,6E)-2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) treatment on MCF-7 breast cancer cells
by: Yeap, Swee Keong, et al.
Published: (2021)

Induction of apoptosis and regulation ofMicroRNA expression by (2E,6E)-2,6-bis-(4-hydroxy-3-methoxybenzylidene)- cyclohexanone (BHMC) treatment on MCF-7 breast cancer cells
by: Yeap, S. K., et al.
Published: (2021)

Antinociceptive activity of a synthetic curcuminoid analogue, 2,6-bis-(4-hydroxy-3-methoxybenzylidene)cyclohexanone, on nociception-induced models in mice.
by: Lee, Ming Tatt, et al.
Published: (2012)

The molecular targets and anti-invasive effects of 2,6-bis-(4-hydroxyl-3methoxybenzylidine) cyclohexanone or BHMC in MDA-MB-231 human breast cancer cells
by: Harun, Siti Nor Aini, et al.
Published: (2018)

Chemopreventive effects of a curcumin‐like diarylpentanoid [2,6‐bis(2,5‐dimethoxybenzylidene)cyclohexanone] in cellular targets of rheumatoid arthritis in vitro
by: Lee, Ka Heng, et al.
Published: (2015)

A synthetic curcuminoid analogue, 2,6-Bis-4-(Hydroxyl-3-Methoxybenzylidine)-Cyclohexanone (BHMC) ameliorates acute airway inflammation of allergic asthma in ovalbumin-sensitized mice
by: Tham, Chau Ling, et al.
Published: (2021)

Antinociceptive profile of a synthetic curcuminoid derivative, 2,6-bis-4-(hydroxy-3-methoxy-benzilidine)-cyclohexanone in murine model of induced-nociception
by: Lee, Ming Tatt
Published: (2013)

Immunomodulatory action of new curcumin analogue [2,6-BIS(2,5-dimethoxybenzylidene) cyclohexanone] on major inflammatory mediator expression in activated macrophage and synovial fibroblast cells
by: Lee, Ka Heng
Published: (2012)

Cytotoxic Effect of Girinimbine on HepG2 Cells
by: Mohan, Suvita Syam
Published: (2011)

Toxicity effects of curcumin analogue, 2, 6-BIS (2-fluorobenzylidene) cyclohexanone on zebrafish (Danio rerio F. Hamilton, 1822)
by: Nazarudin, Nur Amiza
Published: (2017)

Anti-metastasis Effects and Mechanism of Action of Curcumin Analog (2E,6E)-2,6-bis(2,3-dimethoxybenzylidene) Cyclohexanone (DMCH) on the SW620 Colorectal Cancer Cell Line
by: Che Rahim, Nurul Fattin, et al.
Published: (2025)

Zerumbone Exerts Antiproliferative Activity via Apoptosis on HepG2 Cells
by: Syed Alwi, Sharifah Sakinah, et al.
Published: (2007)

A curcumin derivative, 2,6-bis(2,5-dimethoxybenzylidene)-cyclohexanone (BDMC33) attenuates prostaglandin E2 synthesis via selective suppression of cyclooxygenase-2 in IFN-γ/LPS-stimulated macrophages..
by: Lee, Ka Heng, et al.
Published: (2011)

Cytotoxicity and apoptosis effects of curcumin analogue (2E,6E)-2,6-Bis(2,3-Dimethoxybenzylidine) cyclohexanone (DMCH) on human colon cancer cells HT29 and SW620 in vitro
by: Nurul Fattin, Che Rahim, et al.
Published: (2021)

Cytotoxicity and apoptosis effects of curcumin analogue (2E,6E)-2,6-Bis(2,3-Dimethoxybenzylidine) Cyclohexanone (DMCH) on human colon cancer cells HT29 and SW620 in vitro
by: Che Rahim, Nurul Fattin, et al.
Published: (2021)

Effects of thymoquinone and thymoquinone-loaded nanostructured lipid carrier on hepatocellular carcinoma cell models, Hep3B and HepG2
by: Haron, Aminah Suhaila
Published: (2017)

Thymoquinone-loaded nanostructured lipid carrier reduces proliferation of human liver cancer cells, HepG2
by: Mustafa Azmy, Nurfahima, et al.
Published: (2019)

Synthesis, Spectral Characterization and Crystal Structure of (E)-4- Hydroxy-N -(2-methoxybenzylidene) benzohydrazide
by: Rassem, Hesham H. A., et al.
Published: (2016)

Antioxidant behaviour of carotenoids highly accumulated in HepG2 cells
by: Jaswir, Irwandi, et al.
Published: (2012)

Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells.
by: Al-Qubaisi, Mothanna, et al.
Published: (2011)

Synthesis, NMR spectroscopy and crystal structures studies of 2-amino-N-(2-hydroxy-3-methoxybenzylidene) aniline
by: Al-Douh, Mohammed Hadi, et al.
Published: (2009)

1-[(E)-(3-Hydroxy-4-methoxybenzylidene)amino]- 3-methylthiourea
by: Arafath, Md. Azharul, et al.
Published: (2016)

Effects of curcumin analogue, 2, 6-bis (2, 5-dimethoxybenzylidene) cyclohexanone (BDMC33) on the activities of drug-metabolizing enzymes in cultured Caco-2 cell model
by: Yakubu, Ndatsu, et al.
Published: (2016)

Curcumin derivative, 2,6-bis(2-fluorobenzylidene)cyclohexanone (MS65) inhibits interleukin-6 production through suppression of NF-κB and MAPK pathways in histamine-induced human keratinocytes cell (HaCaT)
by: Razali, Nurul Atika, et al.
Published: (2018)

Use of the curcumin analog BHMC in the treatment of endothelial dysfunction and related disorders
by: Israf Ali, Daud Ahmad, et al.
Published: (2012)

Adverse effects of anti-tuberculosis drugs on HepG2 cell bioenergetics
by: Elmorsy, E., et al.
Published: (2016)

Gamma-tocotrienol alters protein expression of HepG2 cell line
by: Farahani ARS,, et al.
Published: (2008)

Suppression effect of eurycomanone on the growth of HepG2 tumour transplanted in mice
by: Zakaria, Yusmazura
Published: (2011)

Cytotoxicity of Clinacanthus Nutans Extracts on Human Hepatoma (HepG2) Cell Line
by: Hazrulrizawati, Hamid, et al.
Published: (2016)

Regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by thymoquinone-rich fraction and thymoquinone in HepG2 cells
by: Al-Naqeep, Ghanya, et al.
Published: (2009)

Monechma ciliatum methanolic extract regulates low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase genes expression in HepG2 cells
by: Mariot, Abdalbasit Adam, et al.
Published: (2010)

Regulation of p53-, Bcl-2- and Caspase-dependent Signaling Pathway in Xanthorrhizol-induced Apoptosis of HepG2 Hepatoma Cells
by: Tri Handayani,, et al.
Published: (2007)

Role of oxidative stress in antituberculous drugs (individuals and combined) cytotoxicity in HepG2 cells
by: Elmorsy, Ekramy, et al.
Published: (2016)

Eurycomanone induce apoptosis in HepG2 cells via up-regulation of p53
by: Zakaria, Yusmazura, et al.
Published: (2009)

Vanillin rich fraction regulates LDLR and HMGCR gene expression in HepG2 cells.
by: Ismail, Maznah, et al.
Published: (2010)

Cytotoxic effects of conjugated linoleic acids on human hepatoma cancer cells (HepG2)
by: Melaku, Achenef, et al.
Published: (2012)